Intervet/Schering-Plough Animal Health’s Q3 Dips 12%


Intervet/Schering-Plough Animal Health recently reported revenue of $669 million for its third quarter ended Sept. 30, a 12 percent decrease compared to $759 million in the year-ago period.

The sales decline was primarily due to the overall economic environment, difficult comparisons against the 2008 launch of bluetongue vaccine and back orders on certain products, according to the company, adding that the back orders were due primarily to the ongoing integration of animal health manufacturing practices and quality standards.

Year to date, Intervet/Schering-Plough Animal Health reported revenue of $2 billion, a 14 percent decrease compared to $2.3 billion in the year-ago period.

Intervet/Schering-Plough Animal Health’s parent company, Schering-Plough, reported net income of $515 million on revenue of $4.5 billion for its third quarter, compared to net income of $614 million on revenue of $4.6 billion in the year-ago period.

Year to date, Schering-Plough reported net income of $2 billion on revenue of $13.5 billion, compared to net income of $1.4 billion on revenue of $14.2 billion.


Archive »Read More

NCSU to Host 23nd Annual Dog Olympics Sept. 13

The aim of the event is to celebrate the human-animal bond and raise money for local animal rescue groups.

Michigan State University Co-Hosts 10th Annual Marek’s Disease Symposium

MSU and the USDA’s Avian Disease and Oncology Laboratory recently co-hosted a symposium on Marek’s disease and avian herpesvirus.

Too Many Veterinarians, or a Bubble Market?

How can a scientifically trained profession keep ignoring the facts of too many graduates chasing too few jobs with an ever increasing debt burden?

Add your comment:


Show More...